HK1115315A1 - Tablet containing hardly soluble active ingredient - Google Patents

Tablet containing hardly soluble active ingredient

Info

Publication number
HK1115315A1
HK1115315A1 HK08109975.2A HK08109975A HK1115315A1 HK 1115315 A1 HK1115315 A1 HK 1115315A1 HK 08109975 A HK08109975 A HK 08109975A HK 1115315 A1 HK1115315 A1 HK 1115315A1
Authority
HK
Hong Kong
Prior art keywords
active ingredient
hardly soluble
tablet containing
soluble active
containing hardly
Prior art date
Application number
HK08109975.2A
Other languages
English (en)
Inventor
Makoto Fukuta
Shigeyuki Marunaka
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37570471&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1115315(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of HK1115315A1 publication Critical patent/HK1115315A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK08109975.2A 2005-06-22 2008-09-08 Tablet containing hardly soluble active ingredient HK1115315A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005182415 2005-06-22
PCT/JP2006/312419 WO2006137443A1 (ja) 2005-06-22 2006-06-21 難溶性の有効成分を含有する錠剤

Publications (1)

Publication Number Publication Date
HK1115315A1 true HK1115315A1 (en) 2008-11-28

Family

ID=37570471

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08109975.2A HK1115315A1 (en) 2005-06-22 2008-09-08 Tablet containing hardly soluble active ingredient

Country Status (18)

Country Link
US (1) US8821926B2 (xx)
EP (1) EP1900368B1 (xx)
JP (1) JP5220408B2 (xx)
KR (1) KR20080027783A (xx)
CN (1) CN101247805B (xx)
AU (1) AU2006260201B2 (xx)
BR (1) BRPI0611618A2 (xx)
CA (1) CA2612090C (xx)
CR (1) CR9632A (xx)
ES (1) ES2366381T3 (xx)
HK (1) HK1115315A1 (xx)
IL (1) IL187916A (xx)
MX (1) MX2007015783A (xx)
NO (1) NO20080248L (xx)
NZ (1) NZ564407A (xx)
RU (1) RU2420278C2 (xx)
WO (2) WO2006137443A1 (xx)
ZA (1) ZA200711048B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5361188B2 (ja) * 2006-08-10 2013-12-04 武田薬品工業株式会社 医薬組成物
WO2009084023A2 (en) * 2007-10-19 2009-07-09 Glenmark Generics Limited Amorphous ramelteon and process for the preparation thereof
CN102292075B (zh) * 2009-01-21 2013-04-17 弗·哈夫曼-拉罗切有限公司 包含hcv聚合酶抑制剂前药的药物组合物
TWI438200B (zh) * 2009-02-17 2014-05-21 必治妥美雅史谷比公司 Ｃ型肝炎病毒抑制劑
WO2012103411A2 (en) 2011-01-28 2012-08-02 Zx Pharma, Llc Controlled-release melatonin composition and related methods
US9532952B2 (en) 2011-01-28 2017-01-03 Physician's Seal, LLC Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients
CN103989643B (zh) * 2013-07-26 2018-10-30 武汉先路医药科技有限公司 含有雷美替胺和共聚维酮的片剂
CN104546746A (zh) * 2013-10-28 2015-04-29 南京长澳医药科技有限公司 一种雷美替胺片剂及其制备工艺
WO2017192843A1 (en) 2016-05-06 2017-11-09 Physician's Seal, LLC Valerian composition and related methods
JP7407364B2 (ja) * 2019-02-12 2024-01-04 日本ジェネリック株式会社 ラメルテオン含有固形製剤

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
US6034239A (en) * 1996-03-08 2000-03-07 Takeda Chemical Industries, Ltd. Tricyclic compounds, their production and use
NZ330656A (en) * 1996-03-08 1999-06-29 Takeda Chemical Industries Ltd Tricyclic compounds, their production and use
JP2884153B2 (ja) * 1996-03-08 1999-04-19 武田薬品工業株式会社 三環性化合物、その製造法および剤
JPH11322584A (ja) * 1998-05-07 1999-11-24 Sawai Pharmaceutical Co Ltd ベザフィブラート徐放性製剤
WO1999063977A2 (en) * 1998-06-09 1999-12-16 Takeda Chemical Industries, Ltd. Pharmaceutical combination comprising a tricyclic compound and at least one of zolpidem, zopiclone, triazolam and brotizolam for treating or preventing sleep disorders
AU6589200A (en) * 1999-09-10 2001-04-17 Ranbaxy Laboratories Limited Extended release formulation of etodolac
EP2305219A1 (en) * 2000-11-17 2011-04-06 Takeda Pharmaceutical Company Limited Pharmaceutical preparations coated with a copolyvidone-containing coating
JP4848558B2 (ja) * 2001-05-08 2011-12-28 トーアエイヨー株式会社 塩酸メトホルミン含有速放性錠剤
JP4754211B2 (ja) * 2004-12-28 2011-08-24 ライオン株式会社 粒状医薬組成物及びその製造方法

Also Published As

Publication number Publication date
NO20080248L (no) 2008-01-14
ZA200711048B (en) 2009-05-27
ES2366381T3 (es) 2011-10-19
AU2006260201A1 (en) 2006-12-28
IL187916A0 (en) 2008-03-20
US8821926B2 (en) 2014-09-02
CA2612090C (en) 2014-06-10
AU2006260201B2 (en) 2011-10-20
IL187916A (en) 2013-11-28
CN101247805B (zh) 2012-10-10
BRPI0611618A2 (pt) 2011-05-31
EP1900368B1 (en) 2011-05-11
CN101247805A (zh) 2008-08-20
RU2420278C2 (ru) 2011-06-10
WO2006137443A1 (ja) 2006-12-28
WO2007004425A1 (ja) 2007-01-11
KR20080027783A (ko) 2008-03-28
RU2008102238A (ru) 2009-07-27
JPWO2006137443A1 (ja) 2009-01-22
CR9632A (es) 2008-02-04
EP1900368A1 (en) 2008-03-19
CA2612090A1 (en) 2006-12-28
JP5220408B2 (ja) 2013-06-26
MX2007015783A (es) 2008-02-21
EP1900368A4 (en) 2009-08-12
US20090036522A1 (en) 2009-02-05
NZ564407A (en) 2011-03-31

Similar Documents

Publication Publication Date Title
HK1115315A1 (en) Tablet containing hardly soluble active ingredient
PT1850664E (pt) Formulação de cápsulas
IL177566A0 (en) Pharmaceutical formulations
IL185390A (en) A solid dosage form
PL1876897T3 (pl) Kombinacje substancji czynnych
ZA200709999B (en) Fungicidal active ingredient combination
HK1121950A1 (en) Stable pharmaceutical composition comprising a pyrimidine-sulfamide
EP1948543A4 (en) DISPENSER OF TABLETS
GB0426301D0 (en) Pharmaceutical formulations
GB2414462B (en) Active container
IL190698A0 (en) Nanoparticulate active ingredient formulations
IL184067A0 (en) Tablet formulation for sustained drug-release
ZA200709788B (en) Cannabinold active pharmaceutical ingredient for Improved dosage forms
ZA200804757B (en) Fungicidal active ingredient combination
ZA200803152B (en) Oramucosal pharmaceutical dosage form
ZA200804952B (en) Fungicidal active substance combination
GB0416397D0 (en) Pharmaceutical formulations
HK1105358A1 (en) Solid pharmaceutical formulation
GB0406048D0 (en) Drug formulations
EP1844770A4 (en) ORNITHINHYDROCHLORIDE-CONTAINING TABLETS
GB0417042D0 (en) Stable pharmaceutical formulation
GB0515937D0 (en) Pharmaceutical formulation
GB0418270D0 (en) Pharmaceutical formulation
GB0422111D0 (en) Pharmaceutical formulation
GB0514530D0 (en) Pharmaceutical agent

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20150621